saccharomyces boulardii and Reduced Dyspepsia Symptoms

• Efficacy and Safety of Saccharomyces boulardii in the 14‐day Triple Anti‐Helicobacter pylori Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind Study

  • 2007-07-30
  • RCT
  • Helicobacter 12(4)
  • • M. Cindoruk
    • Gulbanu Erkan
    • T. Karakan
    • A. Dursun
    • S. Unal

  • PubMed: 17669103
  • DOI: 10.1111/j.1523-5378.2007.00516.x

  5 Insights on

  • Reduced Dyspepsia Symptoms

  • High evidence
  • Highly Cited

  GDQ scores after treatment were significantly better for treatment group (mean +/- SD, range: 1.38 +/- 1.25 (0-5) vs. 2.22 +/- 1.44 (0-6), respectively; p < .01).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

  Dose

  Not stated in abstract